| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥13.2B | ¥18.3B | -28.1% |
| Operating Income | ¥-1.2B | ¥-2.6B | +51.2% |
| Ordinary Income | ¥-1.3B | ¥-2.5B | +49.0% |
| Net Income | ¥-0.2B | ¥-2.7B | +92.3% |
| ROE | -12.1% | -141.2% | - |
FY2025 Q3 (nine-month cumulative) results showed revenue of 13.2B yen (YoY -28.1%), operating loss of -1.2B yen (YoY improvement +51.2%), ordinary loss of -1.3B yen (YoY improvement +49.0%), and net loss of -0.2B yen (YoY improvement +92.3%). Despite significant top-line contraction, all profit metrics improved substantially year-over-year, with net loss narrowing from -2.7B yen to -0.2B yen. Basic EPS improved to -0.78 yen from -15.18 yen (YoY +94.9%). The company continues to operate at a loss but demonstrates clear momentum in loss reduction, primarily driven by cost structure improvements that more than offset revenue declines.
Revenue declined 28.1% YoY to 13.2B yen, with the Sweets segment falling 28.1% to 12.1B yen and Beauty and Health segment declining 28.4% to 1.1B yen. The revenue contraction affected both core business lines proportionally, suggesting company-wide headwinds rather than segment-specific issues. Despite the sharp revenue decline, gross profit reached 3.5B yen with a margin of 26.7%, while SG&A expenses totaled 4.8B yen, representing 36.2% of revenue. The SG&A ratio increased from the implied prior year level due to the revenue base shrinkage, though absolute SG&A expenses appear to have been controlled. Operating loss improved significantly to -1.2B yen from -2.6B yen, indicating operating leverage improvement through cost rationalization. Non-operating expenses totaled 0.1B yen net, primarily comprising interest expenses of 0.1B yen against minimal non-operating income. Extraordinary income of 1.1B yen was recorded as a non-recurring factor, substantially improving the bottom line, while extraordinary losses of 0.1B yen were minimal. The 1.0B yen gap between ordinary loss of -1.3B yen and net loss of -0.2B yen is explained by the extraordinary gain of approximately 1.0B yen net of tax impacts. This represents a revenue down, profit improving pattern, driven primarily by operational cost reductions and one-time extraordinary gains.
The Sweets segment generated revenue of 12.1B yen with an operating loss of -0.9B yen, representing a -7.4% margin. This is the core business, accounting for 91.9% of total revenue. The Beauty and Health segment recorded revenue of 1.1B yen with operating profit of 1.0B yen and a remarkable 92.7% margin. Despite its small scale at 8.1% of total revenue, the Beauty and Health segment is highly profitable and generated segment profit exceeding its cost structure. The stark margin difference between segments (-7.4% vs 92.7%) indicates the Sweets business bears the majority of fixed costs and operational challenges, while Beauty and Health operates on a significantly leaner, higher-margin model. Unallocated corporate expenses of -0.1B yen were minimal, with total operating loss of -1.2B yen after segment profit aggregation of 0.0B yen (1.0B yen profit less 0.9B yen loss).
[Profitability] ROE of -12.1% reflects negative earnings against a severely constrained equity base of 1.7B yen. Operating margin of -9.5% improved from the prior year's deeper loss but remains negative, indicating the company has yet to achieve breakeven on an operating basis. Net profit margin of -1.6% represents significant improvement from prior periods through cost reductions and extraordinary gains. [Cash Quality] Cash and deposits stood at 2.3B yen, providing coverage of 16.4x against short-term borrowings of 0.1B yen and strong short-term debt serviceability. Inventory levels reached 2.4B yen, representing 18.2% of total assets and an inventory turnover period of approximately 91 days. [Investment Efficiency] Asset turnover of 1.13x demonstrates moderate efficiency in asset utilization, exceeding the industry median of 0.82x and indicating relatively effective revenue generation per asset base despite the revenue decline. [Financial Health] Equity ratio of 14.5% is severely below the industry median of 52.3%, reflecting an overleveraged capital structure with total assets of 11.7B yen supported by only 1.7B yen in equity. Current ratio of 146.2% (current assets 7.8B yen vs. current liabilities 5.3B yen) and quick ratio of 101.2% indicate adequate short-term liquidity. Debt-to-equity ratio of 5.90x is substantially elevated, with long-term loans of 2.4B yen and total liabilities of 10.0B yen placing significant financial risk on the company. Retained earnings of -1.8B yen improved dramatically from -13.0B yen in the prior year, indicating substantial capital restructuring or extraordinary gain realization that reduced accumulated deficits.
Cash and deposits decreased 1.4B yen YoY to 2.3B yen, representing a 36.8% decline despite operating loss improvements, indicating cash consumption during the period. Working capital movements show notable inventory accumulation, with inventories increasing 1.2B yen (+107.2%) to 2.4B yen, representing a significant cash outflow and potential demand-supply mismatch risk. Trade payables increased 0.5B yen (+42.3%) to 1.6B yen, partially offsetting inventory buildup through improved supplier credit utilization. Total current assets declined modestly by 0.3B yen to 7.8B yen while current liabilities remained relatively stable, suggesting controlled working capital despite inventory pressures. Short-term borrowings decreased sharply by 0.3B yen (-69.5%) and long-term loans declined 1.2B yen (-33.6%), indicating active debt reduction activities that consumed available cash. Net debt position improved through borrowing reductions, though the cash decline of 1.4B yen against debt reduction of 1.6B yen total suggests cash was allocated toward deleveraging. Liquidity coverage remains adequate with cash-to-short-term liabilities at 0.43x and total current asset coverage at 1.46x, supporting near-term financial stability despite negative operating cash characteristics.
Ordinary loss of -1.3B yen compared to operating loss of -1.2B yen reflects net non-operating expenses of approximately 0.1B yen, primarily consisting of interest expenses totaling 0.1B yen with negligible non-operating income. Non-operating income contribution is minimal at less than 1% of revenue, indicating limited reliance on financial or investment income. The most significant earnings quality consideration is the extraordinary income of 1.1B yen, which drove the improvement from ordinary loss of -1.3B yen to net loss of only -0.2B yen. This extraordinary gain represents a non-recurring factor that accounts for approximately 83% of the bottom-line improvement and should not be viewed as sustainable earnings power. Absent the extraordinary gain, pre-tax loss would have remained at approximately -1.3B yen, consistent with ordinary loss levels. While detailed operating cash flow data is unavailable for the quarterly period, the sharp inventory increase of 1.2B yen and cash decline of 1.4B yen suggest operating cash generation was negative or minimal, indicating earnings quality concerns related to working capital consumption. The combination of operating losses, working capital outflows, and dependence on one-time gains for bottom-line improvement suggests underlying earnings quality remains weak and requires structural operational improvement for sustainable profitability.
Full-year guidance projects revenue of 17.8B yen (YoY -24.1%), operating loss of -0.3B yen, and ordinary loss of -0.2B yen, with EPS forecast of 1.44 yen. Q3 cumulative progress against full-year guidance shows revenue achievement of 74.1% (13.2B yen of 17.8B yen target), which is below the standard Q3 progress rate of 75%, suggesting Q4 must deliver approximately 4.6B yen to meet guidance. Operating loss of -1.2B yen cumulative through Q3 compares to full-year guidance of -0.3B yen loss, implying Q4 must generate operating profit of approximately 0.9B yen to achieve guidance, representing a significant quarterly turnaround from the loss-making trend. The deviation indicates either seasonal factors expected to drive strong Q4 performance or potential conservatism in the original guidance. The company has not revised guidance this quarter, maintaining original projections despite Q3 progress rates suggesting execution challenges. The full-year EPS guidance of 1.44 yen implies net income of approximately 38M yen for the full year, which would require Q4 net income of approximately 58M yen after Q3 cumulative net loss of -20M yen. Given Q3 results benefited from 1.1B yen in extraordinary gains, achieving positive full-year EPS will depend heavily on Q4 operational performance improvement and potential additional non-recurring items. Forward revenue visibility remains limited in the absence of order backlog disclosure.
The company has announced zero dividend for the forecast period, maintaining no dividend distribution policy. With no dividend payments planned and net loss conditions persisting, the payout ratio is not applicable. No share buyback activity has been disclosed. The absence of shareholder returns reflects the company's priority on financial restructuring, debt reduction, and return to profitability before resuming capital distributions. Given the equity ratio of only 14.5%, debt-to-equity of 5.90x, and ongoing operating losses, the zero dividend policy is appropriate and necessary to preserve capital for operational recovery and financial stability. Resumption of dividends would require sustained return to profitability, improved cash generation, and material deleveraging.
Revenue contraction risk remains the primary concern, with sales declining 28.1% YoY across both major segments, indicating broad-based demand weakness or market share loss that, if sustained, would prevent return to profitability. Inventory buildup risk is quantifiable, as inventories surged 107.2% to 2.4B yen (91 days of sales), creating exposure to obsolescence, markdowns, or write-downs that could generate future losses and further strain working capital. Financial leverage risk is acute, with debt-to-equity of 5.90x and equity ratio of only 14.5%, leaving minimal buffer against covenant violations or refinancing difficulties; interest coverage remains deeply negative at -20.52x, indicating earnings are insufficient to service interest expenses of 0.1B yen, creating potential default risk if profitability does not improve.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE -12.1% significantly underperforms the industry median of 8.1% (2025-Q3, n=10), reflecting ongoing net losses and extremely low equity base. Operating margin of -9.5% is well below the industry median of 4.7% (IQR: 1.8%-12.4%), indicating severe operational challenges compared to peers. Net profit margin of -1.6% trails the industry median of 6.5% (IQR: 3.6%-13.5%), confirming the company's profitability gap. Financial Health: Equity ratio of 14.5% is substantially below the industry median of 52.3% (IQR: 35.5%-60.6%), placing the company in the bottom quartile for capital structure strength. Current ratio of 1.46x is below the industry median of 2.03x (IQR: 1.63x-3.24x), though still within an acceptable range for near-term solvency. Efficiency: Operating margin deficit places the company below industry standards, while asset turnover of 1.13x exceeds the industry median of 0.82x (IQR: 0.44-1.06), indicating relative efficiency in revenue generation per asset despite profitability challenges. Inventory turnover period of 91 days exceeds the industry median of 35 days (IQR: 15-87 days), confirming inventory management as an area of concern. Growth: Revenue growth of -28.1% YoY significantly lags the industry median growth of 5.7% (IQR: -1.0%-11.6%), indicating severe underperformance and market position deterioration relative to peers. ※ Industry: Food Products & Retail (estimated 10 comparable companies), Comparison: FY2025 Q3 period, Source: Proprietary analysis
Loss reduction momentum is evident, with operating loss improving 51.2% YoY and net loss improving 92.3% despite a 28.1% revenue decline, demonstrating successful cost structure rationalization that has substantially narrowed losses. However, the improvement is partially attributable to extraordinary gains of 1.1B yen, and sustainable profitability requires continued operational turnaround. Financial structure fragility is the dominant concern, with equity ratio of 14.5%, debt-to-equity of 5.90x, and negative interest coverage of -20.52x indicating severe overleveraging and limited financial flexibility; deleveraging efforts are visible with total borrowings declining 1.6B yen, but restoration of adequate capitalization remains a multi-year challenge. Working capital deterioration through inventory surge of 107.2% coupled with cash decline of 36.8% signals potential liquidity stress and operational inefficiencies that must be addressed through inventory normalization and improved cash conversion. The Q4 outlook embedded in unchanged guidance implies a significant sequential improvement to operating profit of approximately 0.9B yen is required, creating execution risk if seasonal factors or operational initiatives do not materialize as planned. Structural profitability recovery requires both revenue stabilization and continued operating leverage improvement to achieve breakeven and eventually sustainable positive returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.